Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • JnJ

    Tag: jnj

    You Searched For "JnJ"
    AstraZeneca leukemia drug Calquence gets USFDA okay

    AstraZeneca leukemia drug Calquence gets USFDA okay

    Medical Dialogues Bureau24 Nov 2019 10:00 AM IST
    New Delhi: AstraZeneca said late on Thursday that the U.S. Food and Drug Administration (FDA) had given its go-ahead for the company's Calquence drug...
    Johnson and Johnson found negligent in landmark vaginal mesh lawsuit in Australia

    Johnson and Johnson found negligent in landmark vaginal mesh lawsuit in Australia

    Medical Dialogues Bureau23 Nov 2019 9:18 AM IST
    Australia's Federal Court found that Johnson and Johnson (JnJ) subsidiary Ethicon had sold the devices (pelvic mesh implants) without warning women...
    JnJ enters series of new collaborations with Government, NGOs for ending TB in India by 2025

    JnJ enters series of new collaborations with Government, NGOs for ending TB in India by 2025

    Farhat Nasim31 Oct 2019 12:39 PM IST
    Hyderabad: Johnson & Johnson(JnJ) recently announced the expansion of its tuberculosis (TB) program in India in advance of the 50th Union World...
    New tests shows NO sign of asbestos in recalled JnJ baby powder

    New tests shows NO sign of asbestos in recalled JnJ baby powder

    Medical Dialogues Bureau30 Oct 2019 1:18 PM IST
    But Johnson & Johnson (JnJ) said in a statement that dozens of tests by two outside firms did not detect any asbestos in JnJ's baby powder.New...
    Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

    Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

    Medical Dialogues Bureau9 Oct 2019 4:24 PM IST
    Johnson and Johnson said the award was "grossly disproportionate with the initial compensatory award in this case, and the company is confident it...
    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    Medical Dialogues Bureau7 Oct 2019 9:30 AM IST
    NEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    Farhat Nasim19 Sept 2019 9:30 AM IST
    Johnson & Johnson (JnJ), GSK Plc's developmental partner, sell the over-the-counter nicotine oral spray in 45 countries, excluding the United...
    Former JnJ executive Marianne De Backer to lead Bayer pharma division

    Former JnJ executive Marianne De Backer to lead Bayer pharma division

    Medical Dialogues Bureau4 Sept 2019 9:30 AM IST
    Marianne De Backer will take the role of Head of Business Development & Licensing at Bayer's pharmaceuticals division, joining from rival JnJ,...
    Novartis, Lonza strengthen biosimilars push with MS, arthritis drug deals

    Novartis, Lonza strengthen biosimilars push with MS, arthritis drug deals

    Medical Dialogues Bureau3 Sept 2019 9:30 AM IST
    Novartis's Sandoz generics unit, among the biggest biosimilars makers, on Tuesday, agreed to license from Poland's Polpharma Biologics a version of...
    Oklahoma judge to rule in opioid lawsuit against JnJ

    Oklahoma judge to rule in opioid lawsuit against JnJ

    Medical Dialogues Bureau24 Aug 2019 9:10 AM IST
    Lawyers for the state called JnJ an opioid "kingpin" and contended its marketing efforts created a public nuisance in the form of the opioid crisis as...
    Allergan, Endo agree to USD 15 million settlement in major opioid case

    Allergan, Endo agree to USD 15 million settlement in major opioid case

    Medical Dialogues Bureau24 Aug 2019 9:00 AM IST
    Allergan has tentatively agreed to pay $5 million to resolve claims involving its branded opioids, though the deal does not resolve claims involving...
    22-member Committee Constituted to guide CDSCO on Medical Device Regulation

    22-member Committee Constituted to guide CDSCO on Medical Device Regulation

    Farhat Nasim27 July 2019 1:09 PM IST
    New Delhi: To advice the apex drug regulator, Central Drugs Standard Control Organisation (CDSCO) on matters related to the regulation and...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok